WINT - WINDTREE THERAPEUTICS INC /DE/
0.8702
-0.030 -3.425%
Share volume: 69,775
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$0.90
-0.03
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-15-2024 | 08-19-2024 | 11-26-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 4.405 M | 11.452 M | 4.741 M | |
| Selling general and admin | 2.152 M | 1.589 M | 2.773 M | |
| Research and development | 2.253 M | 9.863 M | 1.968 M | |
| Total expenses | 4.405 M | 11.452 M | 4.741 M | |
| 159.98% | -58.60% | |||
| Operating income | -4.405 M | -11.452 M | -4.741 M | |
| Ebit | -4.204 M | -11.737 M | -3.021 M | |
| Pretax income | 10.333 M | -11.827 M | -2.989 M | |
| -214.46% | -74.73% | |||
| Income tax | 114.000 K | 197.000 K | -240.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | 10.219 M | -12.024 M | -2.749 M | |
| -217.66% | 77.14% |
